Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361030
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-01
Brief Title:
Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
HMPL-012-C2-PC01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan Union Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None